ArticleCureus2026
Guillain-Barré Syndrome Following Respiratory Syncytial Virus (RSV) Infection in the Third Trimester: A Case Report of a Rare Entity.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Guillain-Barré syndrome (GBS) is an acute immune-mediated polyradiculoneuropathy affecting the peripheral nervous system, with a range of clinical presentations. GBS in pregnancy is rare and creates diagnostic and management challenges, with limited evidence to guide decisions on the timing and mode of delivery. We report a case of a 37-year-old gravida 4, para 3, who presented at 34+3 weeks of gestation with progressive lower limb weakness, sensory loss, and urinary incontinence. She had received a respiratory syncytial virus (RSV) vaccine shortly before the onset of symptoms. Neurological evaluation, including lumbar puncture and nerve conduction studies, supported a diagnosis of GBS with cranial nerve involvement. The patient was managed with intravenous immunoglobulin (IVIG), physiotherapy, and coordinated multidisciplinary obstetric and anesthetic care. She underwent induction of labor at 37+2 weeks and achieved a spontaneous vaginal delivery of a healthy infant. After delivery, maternal neurological function improved with ongoing physiotherapy. This report highlights the importance of early recognition of GBS in pregnancy, the role of a multidisciplinary team (MDT) in management, and the feasibility of vaginal delivery in appropriately selected patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.